Central Trust Company’s DexCom DXCM Stock Holding History

Central Trust Company’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	4,045 -35	-0.9%	-$2.44K	0.01%	553
2025 Q4	$271K	Sell	4,080 -4	-0.1%	-$259	0.01%	523
2025 Q3	$275K	Buy	4,084 +4	+0.1%	+$317	0.01%	529
2025 Q2	$356K	Sell	4,080 -110	-3%	-$8.62K	0.01%	464
2025 Q1	$286K	Sell	4,190 -15	-0.4%	-$1.22K	0.01%	492
2024 Q4	$327K	Sell	4,205 -64	-1%	-$4.74K	0.01%	479
2024 Q3	$286K	Sell	4,269 -6	-0.1%	-$493	0.01%	491
2024 Q2	$485K	Sell	4,275 -485	-10%	-$61.3K	0.01%	408
2024 Q1	$660K	Sell	4,760 -155	-3%	-$19.5K	0.02%	377
2023 Q4	$610K	Buy	4,915 +45	+0.9%	+$4.6K	0.02%	382
2023 Q3	$454K	Buy	4,870 +100	+2%	+$11.3K	0.01%	421
2023 Q2	$613K	Sell	4,770 -192	-4%	-$23.2K	0.02%	387
2023 Q1	$576K	Sell	4,962 -32	-0.6%	-$3.58K	0.02%	386
2022 Q4	$566K	Sell	4,994 -298	-6%	-$32.7K	0.02%	376
2022 Q3	$426K	Sell	5,292 -236	-4%	-$20K	0.01%	398
2022 Q2	$412K	Buy	5,528 +1,020	+23%	+$93.1K	0.01%	409
2022 Q1	$576K	Buy	4,508 +84	+2%	+$9.19K	0.02%	387
2021 Q4	$594K	Buy	4,424 +24	+0.5%	+$3.45K	0.02%	406
2021 Q3	$602K	Hold	4,400	–	–	0.02%	392
2021 Q2	$470K	Hold	4,400	–	–	0.02%	417
2021 Q1	$395K	Hold	4,400	–	–	0.02%	415
2020 Q4	$407K	Hold	4,400	–	–	0.02%	392
2020 Q3	$453K	Hold	4,400	–	–	0.02%	348
2020 Q2	$446K	Hold	4,400	–	–	0.02%	341
2020 Q1	$296K	Hold	4,400	–	–	0.02%	367
2019 Q4	$241K	Hold	4,400	–	–	0.01%	430
2019 Q3	$164K	Hold	4,400	–	–	0.01%	463
2019 Q2	$168K	Hold	4,400	–	–	0.01%	481
2019 Q1	$131K	Hold	4,400	–	–	0.01%	493
2018 Q4	$132K	Hold	4,400	–	–	0.01%	492
2018 Q3	$157K	Hold	4,400	–	–	0.01%	507
2018 Q2	$104K	Hold	4,400	–	–	0.01%	547
2018 Q1	$82K	Hold	4,400	–	–	0.01%	599
2017 Q4	$63K	Buy	4,400 +400	+10%	+$5.2K	﹤0.01%	666
2017 Q3	$49K	Sell	4,000 -300	-7%	-$5.3K	﹤0.01%	683
2017 Q2	$79K	Buy	4,300 +300	+8%	+$5.54K	0.01%	602
2017 Q1	$85K	Hold	4,000	–	–	0.01%	593
2016 Q4	$60K	Hold	4,000	–	–	﹤0.01%	663
2016 Q3	$88K	Hold	4,000	–	–	0.01%	562
2016 Q2	$79K	Hold	4,000	–	–	0.01%	571
2016 Q1	$68K	Hold	4,000	–	–	0.01%	595
2015 Q4	$82K	Hold	4,000	–	–	0.01%	573
2015 Q3	$86K	Hold	4,000	–	–	0.01%	536
2015 Q2	$80K	Hold	4,000	–	–	0.01%	577
2015 Q1	$62K	Hold	4,000	–	–	0.01%	605
2014 Q4	$55K	Hold	4,000	–	–	﹤0.01%	628
2014 Q3	$40K	Hold	4,000	–	–	﹤0.01%	704
2014 Q2	$40K	Hold	4,000	–	–	﹤0.01%	713
2014 Q1	$41K	Hold	4,000	–	–	﹤0.01%	708
2013 Q4	$35K	Hold	4,000	–	–	﹤0.01%	744
2013 Q3	$28K	Hold	4,000	–	–	﹤0.01%	766
2013 Q2	$22K	Buy	+4,000	New	+$19.2K	﹤0.01%	767

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Central Trust Company's DXCM Position: Q1 2026 in Review

Central Trust Company reduced its DexCom (DXCM) stake by 0.86% in Q1 2026, selling an estimated $2.44K and leaving 4,045 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #553.

Central Trust Company first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $660K in Q1 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Central Trust Company held 4,045 shares of DexCom worth $254K as of Q1 2026.
Central Trust Company sold 35 DexCom shares in Q1 2026, an estimated $2.44K.
DexCom made up 0.01% of Central Trust Company's portfolio in Q1 2026, its #553 holding.
Central Trust Company first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
Central Trust Company's DexCom position peaked at $660K in Q1 2024.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.